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Abstract
Background: Atrial fibrillation (AF) can be treated with percutaneous catheter ablation procedures into the left
atrium. Pulmonary veins stenosis (PV) stenosis is a severe complication of this procedure.
Case presentation: we report a case of late hemoptysis secondary to severe PV stenosis in a man who underwent
AF ablation 9 months before onset of symptoms. He presented four episodes of bleeding and developed an acute
respiratory failure (ARF). Parameters of respiratory mechanics and medical investigation did not show any abnormalities.
Only computed tomography (CT) angiography showed stenosis of 3 out of 4 native PVs. PV balloon dilatation
in all affected PVs and a stent was implanted in 1 of the 3 PVs with full restoration of respiratory function
during 1 year follow-up.
Conclusion: PV stenosis may be the underlying cause of recurrent haemoptysis after AF ablation in the presence of
normal respiratory parameters. This diagnosis can be confirmed by means of CT angiography and magnetic resonance
imaging can provide accurate localization of stenosis.
Keywords: Acute respiratory failure, Haemoptysis, Pulmonary veins stenosis, Atrial fibrillation, Catheters ablation
Background
Massive haemoptysis is characterized by a relevant bron-
chial hemorrhage, usually quantified in 100–1000 ml in
about 24 hours, and it is potentially life-threatening,
representing a medical emergency [1]. When a patient
presents haemoptysis the main clinical problems explored
are infections, tumors, bronchiectasis, malformations, vas-
culitis, coagulative defects [1]. Haemoptysis as a complica-
tion due to cardiac ablation for atrial fibrillation (AF) is
not even take into consideration [2]. However, AF is the
most common clinically important cardiac arrhythmia oc-
curring in 1–2 % of European population. Over 6 million
Europeans suffer from this arrhythmia, which is increasing
in frequency as the population ages [3, 4].
Usually, the first approach to AF is medical therapy or
electric cardioversion. Catheter ablation strategies should
be reserved for patients with AF, which remains symptom-
atic despite optimal medical therapy, or for paroxysmal
AF in young patients with severe symptoms [4].
Percutaneous catheter ablation procedures involve
the application of radiofrequency energy into the left
atrium. Specifically, the technique consists of the elec-
trical isolation of pulmonary veins (PV) from left
atrium by encircling their ostium [3, 5]. Initially, almost
15 years ago, the electrical isolation of PV was per-
formed applying radiofrequency energy, very close to
the ostium, but 7–8 years ago the majority of centers
began avoiding this technique and radiofrequency
energy is now applied outside the ostium of PV thus
reducing the risk of pulmonary vein stenosis (PVS) in
long-term follow-up. Indeed, nowadays PVS after AF
ablation is considered a rare complication. In general,
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the complications of this procedure performed with
standard catheters include cardiac tamponade, systemic
embolism, phrenic and vagus nerve lesion, atrial-
esophageal fistula, pulmonary dysfunction and bleeding
deriving from the anticoagulation required. PVS is a
rare and potentially severe complication of this proced-
ure [5] which occurs in 0.4 % to 1 % of patients, even
in experienced centers [2, 3].
The clinical presentation, investigation, management,
and outcome of this disease have not been completely
explained.
This report describes a case of severe pulmonary vein
stenosis associated with major haemoptysis and ARF
requiring intensive treatment.
Case presentation
A 40-year-old male, heavy smoker, occupational expos-
ure to inhaling substances (his work consisted in floor
tiling), was admitted to our intensive care unit on
December 2013 because of major haemoptysis thus
causing respiratory failure.
The patient’s medical history included hypertension
and AF which began on December 2011, with no re-
sponse to antiarrhythmic medications. In September
2012, the patient underwent catheter ablation for AF in
another hospital. The procedure was conducted as con-
ventionally with irrigated tip radiofrequency electrode.
In particular, circumferential ablation about 1 cm away
from PV orifice for all PVs was performed with max-
imum delivered power 35 watts at pre-set maximum
temperature setting 38 °C. Since July 2013 he referred
the onset of dyspnea and asthenia with several episodes
of spontaneous haemoptysis. In October he was admitted
to a medical ward. Complete blood count, coagulation
study, arterial blood gases, bacterial and fungal cultures,
virologic test, autoimmunity study, electrocardiogram,
chest radiography and Positron Emission Tomography
were carried out, but did not show any abnormalities. An
echocardiogram performed on September 2013, showed a
normal dimension and normal biventricular systolic func-
tion (estimated Ejection Fraction >70 %) and pulmonary
artery pressure was estimated about 25–30 mmHg.
Reumatological and Otolaryngological examinations were
normal. He had no fever, chills, night sweats or weight
loss. A thoraco-abdominal Computed Tomography study,
performed in October 2013, documented the presence of
mediastinal lymphoadenomegalia.
At the beginning of the flexible bronchial endos-
copy, which was aimed at perform transbronchial
fine needle aspiration of the node station 4R, 4 L
and 7 (in order to exclude a proliferative pathology),
the patient had hemorrhaged (about 400 ml in 30 minutes).
The bleeding started immediately spreading from tracheo-
bronchial mucosa. However, the bronchial tree anatomy
was normal, and no evident hemorrhage source was
found. Bleeding was copious and persistent, thus mak-
ing the collection of a sample impossible and orotra-
cheal intubation was required. Then, an angiography of
the bronchial arteries was performed, but it did not
reveal any active source of bleeding. However, a select-
ive embolization was performed because of convoluted
aspect of the bronchial arteries. Following the proced-
ure, the patient was transferred to our intensive care
unit in order to treat the respiratory failure.
Fig. 1 Chest X- ray made just before pronation (see text for further details)
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Subsequently, he presented four more episodes of sud-
den major bleeding with acute desaturation. At the be-
ginning, the oxygenation improved few hours after the
bleeding events. Then the patient became severely hyp-
oxic since the PaO2/FIO2 = 118 with a positive end expira-
tory pressure (PEEP) of 10 cmH2O. The pulmonary
shunt fraction, calculated with the Automatic Lung
Parameter Estimator system (ALPE Essential, Mermaid
Care A/S, Nr. Sundby, Denmark) was about 16 %. A
protective lung ventilation was established. The patient
was paralyzed and ventilated in Volume controlled mode
with a VT of 5.7 ml/Kg and a PEEP of 10 cmH2O. Chest
X-ray showing patchy bilateral infiltrates (Fig. 1). In
order to improve oxygenation, the PEEP level was rise to
15 cmH2O and the shunt fraction decreased to 12 %.
According to our protocol, we decided to prone him; the
oxygenation further ameliorate since the shunt fraction
decreased to 7 %. On the opposite, the static compliance
of the respiratory system (Crs,st), equal to 52 ml/
cmH2O, did not change by rising PEEP and by placing
the patient in prone position. Cst, rs was calculated as
VT/(plateau pressure – PEEPtot), where Plateau pressure
and PEEPtot are the pressure registered after an end in-
spiratory/end expiratory occlusion of at least 5 sec,
respectively. After 24 h of prone position, without
further benefit in terms of oxygenation, the patient
returned in supine position and the curarization was
stopped. The shunt fraction was about 14 % with a
PEEP of 10 cmH2O.
The evident relationship between bleeding events and
hypoxia imposed the re-analysis of the medical history
of the patient. This helped us to notice the temporal cor-
relation with the cardiac ablation. Indeed the latter could
be responsible for severe complications, such as the
PVS. Hence, to clarify this aspect, another Chest CT
angiography was performed, at the seventh day of
hospitalization. This showed the concentric severe sten-
osis of the right superior pulmonary vein (Fig. 2a) and
the 50 % stenosis of both left pulmonary veins (Fig. 2b)
while the right inferior vein appeared ectatic (Fig. 2c).
The patient still intubated was then transferred to the
Specialist Cardiologic Centre in order to perform bal-
loon angioplasty with stent placement of the stenotic
veins since the medical therapy was not able to reverse
the ARF. One week after the procedure, the patient was
successfully extubated.
Discussion
PVS is a relatively rare condition, which can be both con-
genital or acquired. The congenital form is linked almost
completely to congenital heart diseases and inadequate
embryological cardiovascular connections, and evidences
in childhood [6]. In adults, the pathology is even rarer, but
approximately 15 years ago it appears in literature as a
consequence of catheter ablation strategies for arrhyth-
mias [6, 7], arising a bimodal age distribution [6].
The most common causes of acquired PVS in adult
patients are radiofrequency ablation procedures for AF
treatment. However, the underlying molecular mecha-
nisms remain poorly defined, probably involving scar-
ring, contraction of the venous wall and peri-adventitial
inflammation or collagen deposition as a result of ther-
mal injury, which may compromise or even occlude the
lumen of PV [3, 5].
PVS is asymptomatic in most cases, especially when
only one vein is involved. When clinically evident, the
presentation varies depending several factors including:
1) the number of PV involved; 2) the severity of the
lesions; 3) the response of the entire pulmonary vascula-
ture to the lesion; 4) the time course of stenosis; 5) the
clinical setting; and 6) the presence and extent of collat-
eral vessels [3].
Patients with more extensive and severe involve-
ment may present respiratory symptoms like dyspnea,
orthopnea, cough, chest pain, recurrent pulmonary in-
fections. Rarely, does an X-ray show bronchitis or
pneumonia [3, 5].
Haemoptysis, the main symptom described in our case
report, is relatively infrequent [3, 7]. Its etiopathogenesis
has not yet been clarified, but the increase in venous
Fig. 2 a Computed tomography angiography A-P projection showed the concentric severe stenosis of the left superior pulmonary vein (arrow).
b CT angiography A-P projection showed 50 % stenosis of both right superior pulmonary (arrow). c CT angiography A-P projection showed
ectatic right inferior vein (white arrow) and stenosis of left inferior pulmonary vein (black arrow)
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Table 1 Cases of pulmonary vein stenosis with acute respiratory failure complicating trans catheter ablation of atrial fibrillation






19 ● 17 cough ● CT scan ● One placement of
an IVC filter
CT scan role ● Shorter time
correlation with
AF ablation● 12 haemoptysis
● 11 dyspnea on
exertion
● 11 chest pain ● One patient with
partial resection




● 7 dyspnea at rest
● 6 orthopnea ● No mention to
bronchoscopy
● 1 asymptomatic ● Angioplasty
Saad et al.
2003 [20]
21 ● 11 dyspnea ● CT scan Angioplasty ● CT scan role ● Longer time
correlation with
AF ablation● 8 cough ● Treatment
● 8 asymptomatic
● 6 pleuritic chest pain










● CT scan role ● Shorter time
correlation with
AF ablation
● 10 cough ● CT imaging ● Treatment
● 7 dyspnea ● Angiography ● Different
symptoms
● 7 chest pain
● 3 asymptomatic
● 3 flu like symptoms ● No mention
to bronchoscopy
● 2 haemoptysis
● 2 decreased exercise
tolerance




2 ● Hemoptoic sputum






















CT angiography Angioplasty and
stenting
Treatment ● No haemoptysis















AF ablation● Dyspnea on exertion
● Right chest pain ● CT scan ● No mention to
bronchoscopy
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pressure in the pre-stenotic zone could explain the lung
tissue congestion and the risk of bleeding in this area [8].
Interestingly, our patient presented a severe hypoxemia
requiring prone positioning [9]. This acute hypoxemic
respiratory failure was interpreted as a consequence of
repeated bleeding at the mucosal level capable of flooding
the alveoli. It is true that the presence of blood in the
lungs can be impetus for respiratory infections able to
severely decrease oxygenation, such as pneumonia. How-
ever, we did not isolate bacteria in the bronchial aspirates
or in the blood cultures; and the procalcitonin value was
very low (0.04 ng/ml; n.v. <0.05). Further, although strictly
speaking the acute respiratory failure of this patient
could have been classifies as moderate ARDS, the
lungs were not as stiff as in ARDS patients, since the
values of static compliance were higher than those re-
ported for patients with ARDS (33 ml/cmH2O) and
even for patients ventilated for other diseases (44 ml/
cmH2O) [10]. Hence, we thought that the principal
diagnosis should have been different from the first
that was hypothesized. Hemorrhagic pulmonary vas-
culitis was then considered in the differential diagno-
sis and a second CT angiography became mandatory.
The diagnosis of PVS may not be simple to identify,
given the variability of clinical presentation and the atyp-
ical findings. Presence of dyspnea or cough after catheter
ablation in the region of the PV should raise suspicions
of PVS [3, 5]. Our case report suggests that even an ARF
associated with nearly “normal” data of respiratory me-
chanics should imply a CT angiography and, to a lesser
extent, Magnetic Resonance (MR) [11, 12] in order to ex-
clude PVS. Indeed common radiological imaging (Chest
X-ray or CT) is often irrelevant [7, 13]. Consequently,
echocardiography should be routinely performed after AF
ablation, because of the good feasibility, and the overall
benefits in a population with increased risk of PVS devel-
opment [6, 14]. Instead, CT angiography is a valid diag-
nostic tool, even if the resolution sometimes is not
excellent, reducing the possibility to evaluate the stenosis
degree [6, 15]. Furthermore, bronchoscopy has a major
diagnostic role, especially when bleeding is the most rele-
vant symptom, as underlined by international guidelines,
which indicate the endoscopic evaluation as the most
important instrument to investigate haemoptysis, after
CT scans [16]. Nevertheless, there are cases in which
bronchial endoscopy is not even taken into account,
probably because of different clinical presentation
(Table 1). However, the bronchoscopy value is particu-
larly significant in differential diagnosis, in case of a
normal CT, if the patient is high risk for lung carcin-
oma, or if symptoms continue [16].
PVS can be treated acutely with balloon dilatation of
the PV, although the long-term outcome is uncertain [5].
Treatment options are currently limited, and re-stenosis
after PV intervention has been described and considered
relatively frequent [17]. Hence patients with PVS need
careful follow-up because of the risk of recurrence,
which occurs in 50 % of patients within 1 year [6].
Prevention of PVS is mainly related to placing the ab-
lation site from inside to outside the orifice of the PV
and reducing the ablation temperature and energy. This
strategy should decrease the risk of PVS down to less
than 1 % [18, 19].
Conclusions
Clinicians should be aware of the possibility of PVS in pa-
tients who underwent ablation procedure for AF and
those which present haemoptysis and acute hypoxemic re-
spiratory failure. Hence pulmonary venous hypertension
should be considered among the causes of ARF. Presence
of dyspnea, cough, haemoptysis and acute respiratory fail-
ure after catheter ablation in the region of the PV should
raise a high suspicion of PVS and a CT angiography
should be performed since it can provide accurate location
and evaluation of the extent of stenosis.
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